Cargando…

LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment

Senescence is a stress-response process characterized by the irreversible inhibition of cell proliferation, associated to the acquisition of a senescence-associated secretory phenotype (SASP), that may drive pathological conditions. Lymphangioleiomyomatosis (LAM) is a rare disease in which LAM cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardelli, Clara, Ancona, Silvia, Lazzari, Melania, Lettieri, Antonella, Selvaggio, Piera, Massa, Valentina, Gervasini, Cristina, Di Marco, Fabiano, Chiaramonte, Raffaella, Lesma, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266844/ https://www.ncbi.nlm.nih.gov/pubmed/35806041 http://dx.doi.org/10.3390/ijms23137040

Ejemplares similares

Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells
por: Ancona, Silvia, et al.
Publicado: (2021)

Role of Prolactin Receptors in Lymphangioleiomyomatosis
por: Alkharusi, Amira, et al.
Publicado: (2016)

Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
por: Bernardelli, Clara, et al.
Publicado: (2023)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
por: Lesma, Elena, et al.
Publicado: (2015)

Primary TSC2(-/meth) Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
por: Bernardelli, Clara, et al.
Publicado: (2022)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021)

KMT2A: Umbrella Gene for Multiple Diseases
por: Castiglioni, Silvia, et al.
Publicado: (2022)

TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
por: Lesma, Elena, et al.
Publicado: (2014)

“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report
por: Cong, Cung-Van, et al.
Publicado: (2022)

Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study
por: Terraneo, Silvia, et al.
Publicado: (2021)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis
por: Walker, Tarik D., et al.
Publicado: (2015)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

Estradiol Augments the Production and Actions of Polymorphonuclear Cells to Promote Lymphangioleiomyomatosis (LAM) Progression
por: Minor, Briaunna M N, et al.
Publicado: (2021)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer
por: Koc-Günel, Sinem, et al.
Publicado: (2019)

Correction: Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2020)

RF19 | PSUN351 Glycoprotein-NMB (GPNMB) is Pro-Tumorigenic in Lymphangioleiomyomatosis (LAM)
por: Gibbons, Erin, et al.
Publicado: (2022)

The Epidemiology and Clinical Features of Lymphangioleiomyomatosis (LAM): A Descriptive Study of 33 Case Reports
por: Shah, Jaini M, et al.
Publicado: (2023)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis
por: Gloeckl, Rainer, et al.
Publicado: (2020)

THU551 Glycoprotein-NMB (GPNMB) Is A Potential Lymphangioleiomyomatosis (LAM) Therapeutic Target And Biomarker
por: Gibbons, Erin, et al.
Publicado: (2023)

Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2(−)/(−) Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM
por: Lesma, Elena, et al.
Publicado: (2008)

A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM)
por: Banville, Nessa, et al.
Publicado: (2014)

Off-Pump Coronary Artery Bypass Grafting in a Patient with Lymphangioleiomyomatosis (LAM): Navigating the Perioperative Challenges
por: Kumar, Anand, et al.
Publicado: (2023)

Sporadic uterine Lymphangioleiomyomatosis (LAM): Report of a unique case arising in the lower uterine segment with short review
por: Pongsuvareeyakul, Tip, et al.
Publicado: (2021)

Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?
por: Di Marco, Fabiano, et al.
Publicado: (2017)

OR34-5 Infiltrating Neutrophils and Neutrophil Elastase (NE) Promote Tumor Growth in a Mouse Model for Lymphangioleiomyomatosis (LAM)
por: Taya, Manisha, et al.
Publicado: (2019)

Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
por: Giannandrea, Domenica, et al.
Publicado: (2022)

Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
por: Colombo, Michela, et al.
Publicado: (2019)

SUN-134 Estrogen Induces Granulocytic Myeloid Derived Suppressor Cell Production to Potentially Modulate Lymphangioleiomyomatosis (LAM) Tumor Progression
por: Minor, Briaunna, et al.
Publicado: (2020)

Epigenetic disorders: Lessons from the animals–animal models in chromatinopathies
por: Di Fede, Elisabetta, et al.
Publicado: (2022)

Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis
por: Di Marco, Fabiano, et al.
Publicado: (2016)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis
por: Delaney, Sean P., et al.
Publicado: (2014)

Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis
por: Giannandrea, Domenica, et al.
Publicado: (2021)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
por: Dale, Ventour, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_omc57nfu1v566vpisl1ojm9o88